Background: The impact of recent advances of oral antidiabetic agent on insulin users is unclear.

Methods: A retrospective observational and comparative study using medical records of patients who were prescribed insulin at our facility between 2009 and 2017 for various parameters, excluding dialysis patients.

Results: The number of insulin users was almost negligible (309-311 people). The age of the subjects was shifted to the old side on the frequency distribution polygon. The number of subjects who used ≥1 oral antidiabetic agents concurrently increased from 17.0% to 80.0%, especially among those aged >80 years (about 8 times). HbA1c value remained negligible from 8.1% to 8.1%.

Conclusion: Our findings suggest an increasing number of patients with insulin secretory dysfunction masked using of oral antidiabetic agents.

graphic
View largeDownload slide
graphic
View largeDownload slide
Disclosure

A. Kokita: None. M. Araki: None.

© 2019 by the American Diabetes Association.
2019
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.